These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7820021)

  • 1. MR findings of hepatic cavernous hemangioma after intraarterial infusion of iodized oil.
    Choi BI; Shin YM; Chung JW; Kim SH; Park JH; Han MC
    Abdom Imaging; 1994; 19(6):507-11. PubMed ID: 7820021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P; Dufresne AC; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases.
    Choi BI; Han MC; Park JH; Kim SH; Han MH; Kim CW
    AJR Am J Roentgenol; 1989 Jun; 152(6):1221-6. PubMed ID: 2718858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress.
    Glazer GM; Aisen AM; Francis IR; Gyves JW; Lande I; Adler DD
    Radiology; 1985 May; 155(2):417-20. PubMed ID: 3983393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic cavernous hemangioma in patients at high risk for liver cancer.
    Itai Y; Ohnishi S; Ohtomo K; Kokubo T; Imawari M; Atomi Y
    Acta Radiol; 1987; 28(6):697-701. PubMed ID: 2827714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
    Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
    Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cavernous hemangioma of the liver: atypical CT and MR findings.
    Valls C; Reñe M; Gil M; Sanchez A; Narvaez JA; Hidalgo F
    Eur Radiol; 1996; 6(4):448-50. PubMed ID: 8798020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
    Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
    Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipiodol retention within hepatic cavernous hemangioma.
    Uflacker R; Mourão GS; Piske RL
    Cardiovasc Intervent Radiol; 1989; 12(2):76-9. PubMed ID: 2544269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cavernous hemangioma of the liver: pathologic correlation with high-field MR imaging.
    Tung GA; Vaccaro JP; Cronan JJ; Rogg JM
    AJR Am J Roentgenol; 1994 May; 162(5):1113-7. PubMed ID: 8165993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.
    Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM
    AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between hemangiomas and metastases of the liver with ultrafast MR imaging: preliminary results with T2 calculations.
    Goldberg MA; Saini S; Hahn PF; Egglin TK; Mueller PR
    AJR Am J Roentgenol; 1991 Oct; 157(4):727-30. PubMed ID: 1892026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between hepatic cavernous hemangioma and malignant tumor with T2-weighted MRI: comparison of fast spin-echo and breathhold fast spin-echo pulse sequences.
    Soyer P; Dufresne AC; Somveille E; Lenormand S; Scherrer A; Rymer R
    Clin Imaging; 1998; 22(3):200-10. PubMed ID: 9559233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodized-oil retention within hepatic hemangioma: characteristics on iodized-oil CT.
    Moon WK; Choi BI; Han JK; Kim SH; Chung JW; Park JH; Han MC
    Abdom Imaging; 1996; 21(5):420-6. PubMed ID: 8832863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypically enhancing hepatic cavernous hemangiomas: high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings.
    Kato H; Kanematsu M; Matsuo M; Kondo H; Hoshi H
    Eur Radiol; 2001; 11(12):2510-5. PubMed ID: 11734950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions.
    Goldberg MA; Hahn PF; Saini S; Cohen MS; Reimer P; Brady TJ; Mueller PR
    AJR Am J Roentgenol; 1993 May; 160(5):1011-7. PubMed ID: 8470568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemangioma in the cirrhotic liver: diagnosis and natural history.
    Brancatelli G; Federle MP; Blachar A; Grazioli L
    Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
    Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
    AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.